Infusions

Teplizumab is a biologic medication that blunts the autoimmune process that would otherwise destroy insulin-producing beta cells in the pancreas resulting in type 1 diabetes (T1D). 

Treatment involves 14 consecutive daily IV infusions. People who qualify must be 8 years or older, have higher than normal blood glucose (but not diabetic) levels, and have a positive blood test for at least 2 insulin autoantibodies.

AM Diabetes Centers of America offers these infusions to anyone who qualifies, even if they see another doctor for their medical care. Consider being screened for insulin autoantibodies if you are between the ages of  2.5 and 45 years with a first-degree relative (parent, child, sibling) with T1D, ages 2.5 to 20 with a second-degree relative (cousin, grandparent) with T1D, or ages of 2.5 to 45 years and have tested positive for at least one T1D related autoantibody in the past.